| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| ELASOMERAN | 2430046-03-8 | EPK39PL4R4 | CX-024414 ELASOMERAN ELASOMERAN [INN] ELASOMERAN [JAN] ELASOMERAN [WHO-DD] M-1273 MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODONOPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; GENBANK ID MN908947.3) SPIKE (S) GLYCOPROTEIN, FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) AND TERMINATED BY A 3' POLY(A) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.) MODERNA COVID-19 VACCINE RNA MRNA-1273 MRNA-BASED VACCINE ENCODING A PRE-FUSION STABILIZED SPIKE PROTEIN FROM THE 2019-NOVEL CORONAVIRUS (2019-NCOV) RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (986-PROLINE,987-PROLINE)-SPECIFYING POLY(A)-TAILED MESSENGER CX-024414), INNER SALT SPIKEVAX MRNA TAK-919 |